| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |